Skip to main content

CORRECTION article

Front. Med., 15 December 2022
Sec. Dermatology
Volume 9 - 2022 | https://doi.org/10.3389/fmed.2022.1100467
This article is part of the Research Topic Case Reports in Dermatology View all 23 articles

Corrigendum: Case report: A case of anti-laminin 332 mucous membrane pemphigoid associated with severe pharyngolaryngeal involvement

This article is a correction to:

  1. Case report: A case of anti-laminin 332 mucous membrane pemphigoid associated with severe pharyngolaryngeal involvement

    1. Read original article
\nEleonora Quattri, Eleonora Quattri1,2*Martina ZussinoMartina Zussino2Wanda LauroWanda Lauro3Emilio Berti,Emilio Berti1,2Angelo Valerio Marzano,Angelo Valerio Marzano1,2Giovanni Genovese,Giovanni Genovese1,2
  • 1Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy
  • 2Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
  • 3Dermatology and Venereology Section, University of Naples Federico II, Naples, Italy

A corrigendum on
Case report: A case of anti-laminin 332 mucous membrane pemphigoid associated with severe pharyngolaryngeal involvement

by Quattri, E., Zussino, M., Lauro, W., Berti, E., Marzano, A. V., and Genovese, G. (2022). Front. Med. 9:1000954. doi: 10.3389/fmed.2022.1000954

In the published article, there was an error in the Funding statement. [There was no funding statement]. The correct Funding statement appears below.

Funding

This study was partially funded by Italian Ministry of Health, Current research IRCCS.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: laminin 332, mucous membrane pemphigoid, pharyngolaryngeal involvement, paraneoplastic, epiligrin, laminin 5

Citation: Quattri E, Zussino M, Lauro W, Berti E, Marzano AV and Genovese G (2022) Corrigendum: Case report: A case of anti-laminin 332 mucous membrane pemphigoid associated with severe pharyngolaryngeal involvement. Front. Med. 9:1100467. doi: 10.3389/fmed.2022.1100467

Received: 16 November 2022; Accepted: 06 December 2022;
Published: 15 December 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Quattri, Zussino, Lauro, Berti, Marzano and Genovese. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Eleonora Quattri, yes eleonora.quattri@gmail.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.